MedPath
FDA Approval

Insulin Lispro

FDA-approved pharmaceutical product with comprehensive regulatory information, manufacturing details, and complete labeling documentation.

FDA Approval Summary

Company
Eli Lilly and Company
DUNS: 006421325
Effective Date
September 21, 2023
Labeling Type
HUMAN PRESCRIPTION DRUG LABEL
Insulin Lispro(100 [iU] in 1 mL)

Products3

Detailed information about drug products covered under this FDA approval, including NDC codes, dosage forms, ingredients, and administration routes.

Insulin Lispro Junior KwikPen

Product Details

NDC Product Code
0002-7752
Application Number
BLA020563
Marketing Category
BLA (C73585)
Route of Administration
SUBCUTANEOUS
Effective Date
July 21, 2023
GlycerinInactive
Code: PDC6A3C0OXClass: IACTQuantity: 16 mg in 1 mL
MetacresolInactive
Code: GGO4Y809LOClass: IACTQuantity: 3.15 mg in 1 mL
Code: GFX7QIS1IIClass: ACTIBQuantity: 100 [iU] in 1 mL
PhenolInactive
Code: 339NCG44TVClass: IACT
Sodium Phosphate, Dibasic, Unspecified FormInactive
Code: GR686LBA74Class: IACTQuantity: 1.88 mg in 1 mL
WaterInactive
Code: 059QF0KO0RClass: IACT
Sodium hydroxideInactive
Code: 55X04QC32IClass: IACT
Hydrochloric acidInactive
Code: QTT17582CBClass: IACT
ZincInactive
Code: J41CSQ7QDSClass: IACTQuantity: .0197 mg in 1 mL

Insulin Lispro KwikPen

Product Details

NDC Product Code
0002-8222
Application Number
BLA020563
Marketing Category
BLA (C73585)
Route of Administration
INTRAVENOUS, SUBCUTANEOUS
Effective Date
July 21, 2023
GlycerinInactive
Code: PDC6A3C0OXClass: IACTQuantity: 16 mg in 1 mL
Code: GFX7QIS1IIClass: ACTIBQuantity: 100 [iU] in 1 mL
Sodium Phosphate, Dibasic, Unspecified FormInactive
Code: GR686LBA74Class: IACTQuantity: 1.88 mg in 1 mL
MetacresolInactive
Code: GGO4Y809LOClass: IACTQuantity: 3.15 mg in 1 mL
ZincInactive
Code: J41CSQ7QDSClass: IACTQuantity: .0197 mg in 1 mL
PhenolInactive
Code: 339NCG44TVClass: IACT
WaterInactive
Code: 059QF0KO0RClass: IACT
Sodium hydroxideInactive
Code: 55X04QC32IClass: IACT
Hydrochloric acidInactive
Code: QTT17582CBClass: IACT

Insulin Lispro

Product Details

NDC Product Code
0002-7737
Application Number
BLA020563
Marketing Category
BLA (C73585)
Route of Administration
INTRAVENOUS, SUBCUTANEOUS
Effective Date
July 21, 2023
Code: GFX7QIS1IIClass: ACTIBQuantity: 100 [iU] in 1 mL
Sodium Phosphate, Dibasic, Unspecified FormInactive
Code: GR686LBA74Class: IACTQuantity: 1.88 mg in 1 mL
GlycerinInactive
Code: PDC6A3C0OXClass: IACTQuantity: 16 mg in 1 mL
ZincInactive
Code: J41CSQ7QDSClass: IACTQuantity: .0197 mg in 1 mL
PhenolInactive
Code: 339NCG44TVClass: IACT
WaterInactive
Code: 059QF0KO0RClass: IACT
Sodium hydroxideInactive
Code: 55X04QC32IClass: IACT
MetacresolInactive
Code: GGO4Y809LOClass: IACTQuantity: 3.15 mg in 1 mL
Hydrochloric acidInactive
Code: QTT17582CBClass: IACT
© Copyright 2025. All Rights Reserved by MedPath